Bicocca Open Archive

Logo unimib boa
CANTA, ANNALISA ROSANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.230
EU - Europa 6.994
AS - Asia 4.083
SA - Sud America 208
AF - Africa 49
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 23
Totale 22.628
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.025
SG - Singapore 1.755
DE - Germania 1.363
IT - Italia 1.257
CN - Cina 1.089
RU - Federazione Russa 1.003
SE - Svezia 969
IE - Irlanda 834
UA - Ucraina 522
HK - Hong Kong 460
GB - Regno Unito 319
CA - Canada 191
BR - Brasile 179
FI - Finlandia 169
VN - Vietnam 152
AT - Austria 139
FR - Francia 135
ID - Indonesia 126
IN - India 121
JP - Giappone 94
KR - Corea 84
DK - Danimarca 74
NL - Olanda 57
TR - Turchia 48
BE - Belgio 42
IR - Iran 37
AU - Australia 25
PL - Polonia 24
ZA - Sudafrica 22
EU - Europa 20
NZ - Nuova Zelanda 16
PK - Pakistan 16
TW - Taiwan 15
EG - Egitto 13
IL - Israele 12
RO - Romania 12
ES - Italia 10
MY - Malesia 10
CH - Svizzera 9
IQ - Iraq 9
BD - Bangladesh 8
BG - Bulgaria 8
HR - Croazia 8
MX - Messico 8
PT - Portogallo 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
AR - Argentina 6
CZ - Repubblica Ceca 6
EC - Ecuador 5
HU - Ungheria 4
KZ - Kazakistan 4
MA - Marocco 4
PY - Paraguay 4
RS - Serbia 4
UZ - Uzbekistan 4
VE - Venezuela 4
BO - Bolivia 3
CO - Colombia 3
LB - Libano 3
LT - Lituania 3
LV - Lettonia 3
MD - Moldavia 3
NO - Norvegia 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
A1 - Anonimo 2
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
CL - Cile 2
GT - Guatemala 2
JO - Giordania 2
KG - Kirghizistan 2
NG - Nigeria 2
SC - Seychelles 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
TN - Tunisia 1
UY - Uruguay 1
Totale 22.628
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.459
Singapore 1.158
Woodbridge 853
Dublin 816
Chandler 808
Frankfurt am Main 717
Houston 612
Wilmington 545
Jacksonville 535
Milan 504
Fairfield 480
Ashburn 455
Hong Kong 437
Dearborn 436
New York 349
Santa Clara 346
Princeton 282
Seattle 211
Boardman 189
Nanjing 185
Shanghai 150
Cambridge 142
Vienna 130
Jakarta 115
Beijing 101
Guangzhou 87
Lachine 84
Lawrence 80
Dong Ket 77
Altamura 74
Helsinki 67
Shenyang 60
Nanchang 59
Council Bluffs 57
Los Angeles 50
Andover 49
Carate Brianza 49
Chicago 46
Grafing 45
Moscow 45
Toronto 44
Falls Church 42
Fremont 40
Pune 40
Nuremberg 39
San Diego 39
Nürnberg 35
Brussels 34
Jinan 34
Jiaxing 32
Rome 31
Tianjin 30
Kunming 29
Ottawa 28
Tokyo 28
Melzo 26
Norwalk 26
Changsha 25
Daejeon 24
Zhengzhou 24
Hangzhou 23
London 22
Mountain View 22
Sacramento 22
Shangdi 22
Bergamo 18
Hebei 18
São Paulo 18
Codroipo 17
Dallas 16
Hefei 15
Ningbo 15
Washington 15
Leawood 14
Lissone 14
Mainz 14
Edmonton 13
Huizen 13
Seoul 13
Kraków 12
Lappeenranta 12
Shinjuku 12
Taizhou 12
Auburn Hills 11
Bologna 11
Canazei 11
Norristown 11
San Mateo 11
Sesto San Giovanni 11
Düsseldorf 10
Florence 10
Kiev 10
Paris 10
Phoenix 10
Romola 10
Cagliari 9
Kuala Lumpur 9
Rio de Janeiro 9
Wuhan 9
Fuzhou 8
Totale 15.136
Salva come PNG Salva come JPEG
Nome #
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 415
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 330
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 313
Age-related changes in the function and structure of the peripheral sensory pathway in mice 308
Enhanced brain targeting of engineered solid lipid nanoparticles 258
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 253
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 251
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 239
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 230
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 229
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 226
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 224
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 218
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 217
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 213
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain 212
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 212
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 207
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 207
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 207
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 206
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 198
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 196
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 194
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 192
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 192
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 191
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 189
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 189
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 187
A large-field polarisation-resolved laser scanning microscope: Applications to CARS imaging 185
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 184
Enhanced brain targeting of engineered solid lipid nanoparticles 184
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 184
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 182
OCT2 transporter involvement in development of cisplatin toxicity 182
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 179
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 178
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 177
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 176
Effects of different erythropoietin schedules in cisplatin-induced peripheral neurotoxicity 174
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 173
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 172
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 172
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 171
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 170
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 170
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 170
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 167
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 166
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 165
The neuroprotective effect of erythropoietin (EPO) and of its non-erythropoietic carbamylated derivative (CEPO) in cisplatin-induced peripheral neurotoxicity 164
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 164
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 164
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 164
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 162
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 162
Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation 160
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 159
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 159
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 154
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 154
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 151
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 147
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 147
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 146
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 146
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 146
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 144
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 144
Multimodal experimental approach to the study of human neurological diseases 143
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 143
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 143
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 142
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 142
Chemotherapy-induced allodinia: Neuroprotective effect of acetyl-L-carnitine 141
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 141
Genetic factors influencing the development of vincristine-induced neurotoxicity 140
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 139
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 138
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 138
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 136
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 136
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? 136
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 135
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 134
Correlation between organic cation transporter expression in rat dorsal root ganglia neurons and cisplatin-induced peripheral neurotoxicity 133
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 132
Effect of proteasome inhibition on the central and peripheral nervous system 132
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 132
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 131
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 129
Peripheral neurotoxicity induced by cisplatin: a possible role of OCT2 gene 127
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 126
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 126
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 126
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 125
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 125
Organic cation transporters and cisplatin-induced peripheral neurotoxicity in dorsal root ganglia neurons 123
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 122
Totale 17.537
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.108
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020511 0 0 0 0 0 0 0 0 0 254 212 45
2020/20212.832 140 129 318 276 235 254 314 247 241 217 178 283
2021/20221.893 132 194 143 200 168 212 91 89 91 133 144 296
2022/20233.477 363 887 321 358 276 535 61 176 277 56 103 64
2023/20242.911 97 106 106 134 345 709 519 176 136 65 65 453
2024/20255.345 385 826 683 331 581 305 500 256 772 706 0 0
Totale 23.749